Literature DB >> 27699602

Tauroursodeoxycholic Acid Protects Against Mitochondrial Dysfunction and Cell Death via Mitophagy in Human Neuroblastoma Cells.

Inês Fonseca1, Gisela Gordino1, Sara Moreira1, Maria João Nunes1, Carla Azevedo1, Maria João Gama1,2, Elsa Rodrigues1,2, Cecília Maria Pereira Rodrigues1,2, Margarida Castro-Caldas3,4.   

Abstract

Mitochondrial dysfunction has been deeply implicated in the pathogenesis of several neurodegenerative diseases. Thus, to keep a healthy mitochondrial population, a balanced mitochondrial turnover must be achieved. Tauroursodeoxycholic acid (TUDCA) is neuroprotective in various neurodegenerative disease models; however, the mechanisms involved are still incompletely characterized. In this study, we investigated the neuroprotective role of TUDCA against mitochondrial damage triggered by the mitochondrial uncoupler carbonyl cyanide m-chlorophelyhydrazone (CCCP). Herein, we show that TUDCA significantly prevents CCCP-induced cell death, ROS generation, and mitochondrial damage. Our results indicate that the neuroprotective role of TUDCA in this cell model is mediated by parkin and depends on mitophagy. The demonstration that pharmacological up-regulation of mitophagy by TUDCA prevents neurodegeneration provides new insights for the use of TUDCA as a modulator of mitochondrial activity and turnover, with implications in neurodegenerative diseases.

Entities:  

Keywords:  Autophagy; Mitochondria; Mitophagy; Parkin; SH-SY5Y cells; TUDCA

Mesh:

Substances:

Year:  2016        PMID: 27699602     DOI: 10.1007/s12035-016-0145-3

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  64 in total

1.  NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  Du-Chu Wu; Peter Teismann; Kim Tieu; Miquel Vila; Vernice Jackson-Lewis; Harry Ischiropoulos; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

Review 2.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

Review 3.  Mitophagy in neurodegeneration: an opportunity for therapy?

Authors:  R X Santos; S C Correia; C Carvalho; S Cardoso; M S Santos; P I Moreira
Journal:  Curr Drug Targets       Date:  2011-06       Impact factor: 3.465

4.  Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.

Authors:  Y Mizuno; S Ohta; M Tanaka; S Takamiya; K Suzuki; T Sato; H Oya; T Ozawa; Y Kagawa
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

5.  Ubiquitin is phosphorylated by PINK1 to activate parkin.

Authors:  Fumika Koyano; Kei Okatsu; Hidetaka Kosako; Yasushi Tamura; Etsu Go; Mayumi Kimura; Yoko Kimura; Hikaru Tsuchiya; Hidehito Yoshihara; Takatsugu Hirokawa; Toshiya Endo; Edward A Fon; Jean-François Trempe; Yasushi Saeki; Keiji Tanaka; Noriyuki Matsuda
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

6.  Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition.

Authors:  C M Rodrigues; C L Stieers; C D Keene; X Ma; B T Kren; W C Low; C J Steer
Journal:  J Neurochem       Date:  2000-12       Impact factor: 5.372

7.  Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease.

Authors:  Wei-Ming Duan; Cecilia M P Rodrigues; Li-Ru Zhao; Clifford J Steer; Walter C Low; Cecilia M P Rodrigures
Journal:  Cell Transplant       Date:  2002       Impact factor: 4.064

8.  The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro.

Authors:  Marija Dulovic; Maja Jovanovic; Maria Xilouri; Leonidas Stefanis; Ljubica Harhaji-Trajkovic; Tamara Kravic-Stevovic; Verica Paunovic; Mustafa T Ardah; Omar M A El-Agnaf; Vladimir Kostic; Ivanka Markovic; Vladimir Trajkovic
Journal:  Neurobiol Dis       Date:  2013-11-20       Impact factor: 5.996

9.  Dementia in Parkinson's disease is associated with enhanced mitochondrial complex I deficiency.

Authors:  Ariana P Gatt; Olivia F Duncan; Johannes Attems; Paul T Francis; Clive G Ballard; Joseph M Bateman
Journal:  Mov Disord       Date:  2016-02-08       Impact factor: 10.338

10.  Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease.

Authors:  L Lim; V Jackson-Lewis; L C Wong; G H Shui; A X H Goh; S Kesavapany; A M Jenner; M Fivaz; S Przedborski; M R Wenk
Journal:  Cell Death Differ       Date:  2011-08-05       Impact factor: 15.828

View more
  11 in total

1.  TUDCA protects against tunicamycin-induced apoptosis of dorsal root ganglion neurons by suppressing activation of ER stress.

Authors:  Fangyi Chen; Zhe Ge; Nan Li; Zuochong Yu; Rongbo Wu; Yan Zhao; Xianwei He; Guoping Cai
Journal:  Exp Ther Med       Date:  2022-06-10       Impact factor: 2.751

2.  Large-scale production of tauroursodeoxycholic acid products through fermentation optimization of engineered Escherichia coli cell factory.

Authors:  Yingpeng Xu; Li Yang; Shujuan Zhao; Zhengtao Wang
Journal:  Microb Cell Fact       Date:  2019-02-08       Impact factor: 5.328

3.  Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis.

Authors:  Bin Tong; Lin Fu; Biao Hu; Zhi-Cheng Zhang; Zhu-Xia Tan; Se-Ruo Li; Yuan-Hua Chen; Cheng Zhang; Hua Wang; De-Xiang Xu; Hui Zhao
Journal:  BMC Pulm Med       Date:  2021-05-05       Impact factor: 3.317

4.  Tauroursodeoxycholic Acid (TUDCA)-Lipid Interactions and Antioxidant Properties of TUDCA Studied in Model of Photoreceptor Membranes.

Authors:  Michał J Sabat; Anna M Wiśniewska-Becker; Michał Markiewicz; Katarzyna M Marzec; Jakub Dybas; Justyna Furso; Paweł Pabisz; Mariusz Duda; Anna M Pawlak
Journal:  Membranes (Basel)       Date:  2021-04-29

Review 5.  The role of bile acids in carcinogenesis.

Authors:  Tadeja Režen; Damjana Rozman; Tünde Kovács; Patrik Kovács; Adrienn Sipos; Péter Bai; Edit Mikó
Journal:  Cell Mol Life Sci       Date:  2022-04-16       Impact factor: 9.207

Review 6.  Microbiota mitochondria disorders as hubs for early age-related macular degeneration.

Authors:  János Fehér; Ágnes Élő; Lilla István; Zoltán Zsolt Nagy; Zsolt Radák; Gianluca Scuderi; Marco Artico; Illés Kovács
Journal:  Geroscience       Date:  2022-08-18       Impact factor: 7.581

Review 7.  Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.

Authors:  Yixuan Liang; Li Cui; Jiguo Gao; Mingqin Zhu; Ying Zhang; Hong-Liang Zhang
Journal:  Mol Neurobiol       Date:  2021-04-06       Impact factor: 5.590

8.  Optimizing treatment of tauroursodeoxycholic acid to improve embryonic development after in vitro maturation of cumulus-free oocytes in mice.

Authors:  Masato Mochizuki; Kodai Miyagi; Satoshi Kishigami
Journal:  PLoS One       Date:  2018-08-27       Impact factor: 3.240

9.  The Application and Analytical Pathway of Dexmedetomidine in Ischemia/Reperfusion Injury.

Authors:  Ying Tang; Changxin Jia; Jianshuai He; Yang Zhao; Huayong Chen; Shilei Wang
Journal:  J Anal Methods Chem       Date:  2019-12-27       Impact factor: 2.193

Review 10.  Defective Autophagy and Mitophagy in Alzheimer's Disease: Mechanisms and Translational Implications.

Authors:  Jie Chen; Hai-Jun He; Qianqian Ye; Feifei Feng; Wen-Wen Wang; Yingying Gu; Ruiyu Han; Chenglong Xie
Journal:  Mol Neurobiol       Date:  2021-07-19       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.